New hope: boosting the Body's own cells to fight tough ovarian cancer
NCT ID NCT06710288
Summary
This study is testing a three-part treatment for women whose ovarian cancer has returned and stopped responding to standard platinum-based chemotherapy. Doctors will collect a patient's own immune cells, grow and activate them in a lab, and then infuse them back alongside two other drugs (N-803 and gemcitabine) to try to control the cancer. The main goals are to see if this combination is safe and if it can help stop the cancer from growing, shrink tumors, and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATINUM-RESISTANT OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Chan Soon-Shiong Institute for Medicine
RECRUITINGEl Segundo, California, 90245, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hoag
RECRUITINGNewport Beach, California, 92663, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.